Drug shortages can leave patients and those who care for them scrambling.
The Food and Drug Administration’s most recent proposal to help keep a lid on nationwide drug shortages is a move in the right direction but no cure.
It refines a 2012 rule change, adding definitions of what must be reported and how.
“I don’t see how they could further regulate it” beyond that, said Trent Towne, an infectious disease specialist and assistant professor of pharmacy practice at the ManchesterUniversity College of Pharmacy who has lectured on drug shortages.
Towne said he understands where the FDA is coming from, but said there is a sort of Catch-22 involved.
continue to read here